A genome-wide DNA methylation signature for SETD1B-related syndrome

DOI HANDLE HANDLE PDF Web Site ほか1件をすべて表示 一部だけ表示 研究データあり 被引用文献2件 参考文献32件 オープンアクセス

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>SETD1B is a component of a histone methyltransferase complex that specifically methylates Lys-4 of histone H3 (H3K4) and is responsible for the epigenetic control of chromatin structure and gene expression. De novo microdeletions encompassing this gene as well as de novo missense mutations were previously linked to syndromic intellectual disability (ID). Here, we identify a specific hypermethylation signature associated with loss of function mutations in the<jats:italic>SETD1B</jats:italic>gene which may be used as an epigenetic marker supporting the diagnosis of syndromic<jats:italic>SETD1B</jats:italic>-related diseases. We demonstrate the clinical utility of this unique epi-signature by reclassifying previously identified<jats:italic>SETD1B</jats:italic>VUS (variant of uncertain significance) in two patients.</jats:p>

収録刊行物

  • Clinical Epigenetics

    Clinical Epigenetics 11 (1), 156-, 2019-11-04

    Springer Science and Business Media LLC

被引用文献 (2)*注記

もっと見る

参考文献 (32)*注記

もっと見る

関連研究データ

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ